Retatrutide is a synthetic peptide that acts on three receptors: GLP-1, GIP, and glucagon. Research has looked at how it interacts with each of these pathways.
Retatrutide is a synthetic multi-receptor peptide that has been widely studied in laboratory settings for its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is supplied exclusively for controlled laboratory and research use and is intended only for qualified scientific investigation.
As part of Retro Wellness’ research compound range, Retatrutide is presented with a focus on consistency, quality, and responsible sourcing. Each product is intended strictly for qualified research settings and should only be handled by individuals or organisations with the appropriate facilities, knowledge, and procedures.
Research involving Retatrutide has explored its interaction with biological pathways associated with GLP-1 receptor signalling, GIP receptor activation, glucagon receptor modulation, glucose homeostasis, energy balance, metabolic regulation, and endocrine communication. It has also been investigated in broader studies examining multi-agonist receptor biology, mitochondrial energy metabolism, and cellular signalling across a range of experimental models. Ongoing research continues to expand understanding of its biological activity and potential relevance within metabolic, endocrine, and molecular research.
This product is not a medicine, supplement, cosmetic, or food product. It is not intended for human or veterinary use, diagnosis, treatment, prevention, or consumption.
All products available on this site are supplied strictly for laboratory research use only. They are not intended for human or veterinary use, consumption, treatment, diagnosis or therapeutic application. Customers are responsible for ensuring products are handled, stored and used appropriately within a suitable research setting.
